Type 2 Diabetes Mellitus in Children and Adolescents

Overview

Journal World J Diabetes

Publisher Baishideng Publishing Group

Specialty Endocrinology

Date 2014 Jan 1

PMID 24379917

Citations 114

Authors

Thomas Reinehr

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus is emerging as a new clinical problem within pediatric practice. Recent reports indicate an increasing prevalence of type 2 diabetes mellitus in children and adolescents around the world in all ethnicities, even if the prevalence of obesity is not increasing any more. The majority of young people diagnosed with type 2 diabetes mellitus was found in specific ethnic subgroups such as African-American, Hispanic, Asian/Pacific Islanders and American Indians. Clinicians should be aware of the frequent mild or asymptomatic manifestation of type 2 diabetes mellitus in childhood. Therefore, a screening seems meaningful especially in high risk groups such as children and adolescents with obesity, relatives with type 2 diabetes mellitus, and clinical features of insulin resistance (hypertension, dyslipidemia, polycystic ovarian syndrome, or acanthosis nigricans). Treatment of choice is lifestyle intervention followed by pharmacological treatment (e.g., metformin). New drugs such as dipeptidyl peptidase inhibitors or glucagon like peptide 1 mimetics are in the pipeline for treatment of youth with type 2 diabetes mellitus. However, recent reports indicate a high dropout of the medical care system of adolescents with type 2 diabetes mellitus suggesting that management of children and adolescents with type 2 diabetes mellitus requires some remodeling of current healthcare practices.

Citing Articles

Visceral adiposity index, cardiorespiratory fitness, and fasting plasma glucose associations in adolescents.

Musa D, Okuneye R, Momoh J, Darma M, Onoja-Alexander M, Mwangi F World J Clin Pediatr. 2024; 13(4):97105.

PMID: 39654664 PMC: 11572618. DOI: 10.5409/wjcp.v13.i4.97105.

14. Children and Adolescents: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S283-S305.

PMID: 39651980 PMC: 11635046. DOI: 10.2337/dc25-S014.

Downregulation of and Its Impact on and Expression in Type 2 Diabetes Mellitus: Implications for Biomarker Discovery and Disease Pathogenesis.

Rattanapan Y, Nongwa K, Supanpong C, Satsadeedat C, Sai-Ong T, Kooltheat N J Clin Med Res. 2024; 16(11):536-546.

PMID: 39635336 PMC: 11614410. DOI: 10.14740/jocmr6099.

Novel indole based fused triazole-thiadiazole derivatives as anti-diabetic agents: and approaches.

Iqbal T, Khan S, Hussain R, Khan Y, Shoaib K, Rozeena Future Med Chem. 2024; 16(23):2475-2486.

PMID: 39508404 PMC: 11622810. DOI: 10.1080/17568919.2024.2419355.

Temporal relationships between blood glucose, lipids and BMI, and their impacts on atherosclerosis: a prospective cohort study.

Jin S, Liu J, Jia Y, Sun C, Na L BMJ Open. 2024; 14(6):e079521.

PMID: 38839391 PMC: 11163681. DOI: 10.1136/bmjopen-2023-079521.

References

Liu L, Lawrence J, Davis C, Liese A, Pettitt D, Pihoker C . Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes. 2009; 11(1):4-11. DOI: 10.1111/j.1399-5448.2009.00519.x. View

. Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care. 2000; 23(3):381-9. DOI: 10.2337/diacare.23.3.381. View

Uwaifo G, Fallon E, Chin J, Elberg J, Parikh S, Yanovski J . Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care. 2002; 25(11):2081-7. DOI: 10.2337/diacare.25.11.2081. View

Taksali S, Caprio S, Dziura J, Dufour S, Cali A, Goodman T . High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes. 2007; 57(2):367-71. DOI: 10.2337/db07-0932. View

Wilkin T . The accelerator hypothesis: a unifying explanation for type-1 and type-2 diabetes. Nestle Nutr Workshop Ser Clin Perform Programme. 2006; 11:139-153. DOI: 10.1159/000094447. View

Dabelea D, Bell R, DAgostino Jr R, Imperatore G, Johansen J, Linder B . Incidence of diabetes in youth in the United States. JAMA. 2007; 297(24):2716-24. DOI: 10.1001/jama.297.24.2716. View

Schober E, Holl R, Grabert M, Thon A, Rami B, Kapellen T . Diabetes mellitus type 2 in childhood and adolescence in Germany and parts of Austria. Eur J Pediatr. 2005; 164(11):705-7. DOI: 10.1007/s00431-005-1709-9. View

Sabin M . Type 2 diabetes in children. Clin Obes. 2015; 3(3-4):112-6. DOI: 10.1111/cob.12020. View

Arslanian S . Type 2 diabetes mellitus in children: pathophysiology and risk factors. J Pediatr Endocrinol Metab. 2001; 13 Suppl 6:1385-94. DOI: 10.1515/jpem-2000-s612. View

10.

Lobstein T, Frelut M . Prevalence of overweight among children in Europe. Obes Rev. 2003; 4(4):195-200. DOI: 10.1046/j.1467-789x.2003.00116.x. View

11.

Reinehr T, Schober E, Roth C, Wiegand S, Holl R . Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res. 2007; 69(2):107-13. DOI: 10.1159/000111814. View

12.

Awa W, Boehm B, Rosinger S, Achenbach P, Ziegler A, Krause S . HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database. Pediatr Diabetes. 2013; 14(8):562-74. DOI: 10.1111/pedi.12043. View

13.

Shah A, Dolan L, Kimball T, Gao Z, Khoury P, Daniels S . Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009; 94(10):3740-5. PMC: 2758732. DOI: 10.1210/jc.2008-2039. View

14.

Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H . Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord. 2004; 28(2):307-13. DOI: 10.1038/sj.ijo.0802555. View

15.

Dabelea D . The accelerating epidemic of childhood diabetes. Lancet. 2009; 373(9680):1999-2000. DOI: 10.1016/S0140-6736(09)60874-6. View

16.

Kleber M, Desousa G, Papcke S, Wabitsch M, Reinehr T . Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes. 2010; 119(3):172-6. DOI: 10.1055/s-0030-1263150. View

17.

Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T . Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med. 2009; 26(5):466-73. DOI: 10.1111/j.1464-5491.2009.02720.x. View

18.

Reinehr T, Kiess W, Kapellen T, Andler W . Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics. 2004; 114(6):1569-73. DOI: 10.1542/peds.2003-0649-F. View

19.

Liese A, DAgostino Jr R, Hamman R, Kilgo P, Lawrence J, Liu L . The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006; 118(4):1510-8. DOI: 10.1542/peds.2006-0690. View

20.

Copeland K, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K . Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2010; 96(1):159-67. PMC: 3038479. DOI: 10.1210/jc.2010-1642. View